GlassScriptPhysician profile
Emily Merkel
NPI 1497286033
$2,357.63
in general payments reported to CMS, 2019-2025
16 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $20.90 · 2021: $44.08 · 2022: $324 · 2023: $817 · 2024: $373 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.92 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $573.93 | 2019-2025 | |
| Janssen Biotech, INC. | $281.48 | 2022-2025 | Tremfya |
| Pfizer INC. | $276.84 | 2019-2024 | |
| Genzyme Corporation | $247.72 | 2022-2025 | |
| Ucb, INC. | $147.34 | 2022-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $120.63 | 2022-2023 | Dupixent |
| Abeona Therapeutics, INC. | $119.79 | 2025 | Zevaskyn |
| Allergan, INC. | $97.33 | 2019 | |
| Lilly USA, LLC | $92.87 | 2020-2025 | Ebglyss, Taltz |
| Incyte Corporation | $83.30 | 2022-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $75.98 | 2023 | |
| Sun Pharmaceutical Industries INC. | $71.59 | 2022-2024 | Absorica Ld, Winlevi |
| Leo Pharma INC. | $68.60 | 2022-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $48.58 | 2023 | Sotyktu |
| Musculoskeletal Transplant Foundation INC. | $28.35 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.30 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Merkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.